RxDoctor Payments Data

Andrew Bryant

Family Medicine · Madison, WVNPI 1194018093

Payments from drug & device makers

$2,217in general payments, 2019–2025

Across 114 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$320
  • AbbVie$297
  • Novo Nordisk$290
  • Pfizer$256
  • Exact Sciences$225
  • Novartis$138
  • plus $693 from 14 others

What the payments were for

  • Food & beverage$2,217100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,217 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide119$131,549
JardianceEmpagliflozin151$125,274
MounjaroTirzepatide71$86,629
TrulicityDulaglutide66$82,845
EliquisApixaban103$80,092
FarxigaDapagliflozin Propanediol96$78,798
Trelegy ElliptaFluticasone/Umeclidin/Vilanter72$68,050
JanuviaSitagliptin Phosphate73$62,142
EntrestoSacubitril/Valsartan67$52,702
LinzessLinaclotide63$50,782
Tresiba Flextouch U-200Insulin Degludec24$45,327
XareltoRivaroxaban40$28,898
Combivent RespimatIpratropium/Albuterol Sulfate19$18,737
Nurtec OdtRimegepant Sulfate14$17,569
RybelsusSemaglutide18$17,056

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$60$169,475137 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$28$153,598181 claims
Novo NordiskOzempic, Rybelsus$290$148,605137 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$320$105,265161 claims
PfizerEliquis, Nurtec Odt$256$97,661117 claims
GSKTrelegy Ellipta, Breo Ellipta$31$83,927112 claims
MerckJanuvia$100$62,14273 claims
NovartisEntresto$138$52,70267 claims
AbbVieLinzess$297$50,78263 claims
Johnson & JohnsonXarelto$67$28,89840 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Madison

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →